David Schub
4PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Aug 11, 2022
Comparative immunogenicity and reactogenicity of heterologous ChAdOx1-nCoV-19-priming and BNT162b2 or mRNA-1273-boosting with homologous COVID-19 vaccine regimens.Verena Klemis, Tina Schmidt, David Schub
|Sep 01, 2021
Chemoradiotherapy-induced increase in Th17 cell frequency in cervical cancer patients is associated with therapy resistance and early relapse.Laura Theobald, Russalina Stroeder, Patrick Melchior
|Aug 28, 2021
Cellular immunity predominates over humoral immunity after homologous and heterologous mRNA and vector-based COVID-19 vaccine regimens in solid organ transplant recipients.Tina Schmidt, Verena Klemis, David Schub
|Jul 27, 2021
Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination.Tina Schmidt, Verena Klemis, David Schub
Pageof 1
Frequent Collaborators
3 joint publications
Tina Schmidt
3 joint publications
Martina Sester
2 joint publications
Janine Mihm
2 joint publications
Sophie Schneitler
2 joint publications
Urban Sester
1 joint publications
Sören L Becker
1 joint publications
Barbara C Gärtner
1 joint publications
Matthias C Reichert
1 joint publications
Heinrike Wilkens
1 joint publications
Barbara Walch-Rückheim
